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Written Emotional Disclosure for Adults with Type 2 Diabetes: A Primary Care Feasibility Study 
 
 
Abstract 
 Aim 
To test the feasibility of written emotional disclosure (WED) for UK primary care patients with Type 2 
diabetes. 
 
 
Background 
WED holds potential to address depressive symptoms in diabetes, yet its feasibility, and potential 
benefit, for primary care patients has not been established.  
 
 
Method 
Forty-one adults with Type 2 diabetes were randomised to WED (n=23) or neutral writing (n=18). 
Principal outcomes were feasibility of recruitment, compliance, acceptability and intervention 
fidelity. Potential benefit was assessed on between-group differences in depressive symptoms 
(Centre for Epidemiological Studies Depression scale), diabetes distress (Problem Areas in Diabetes 
scale), diabetes self-management behaviours (Summary of Diabetes Self-care Activities 
questionnaire), and perceived health status (EQ-5D) at three month follow-up.  
 
 
Findings 
Recruitment was modest (6%), yet an unmet treatment need was identified. Fourteen intervention 
(61%) and 13(72%) control participants returned their writing, while 12 in each group (89%) then 
completed all sessions. Intervention fidelity was confirmed. Acceptability to patients was mixed. 
Exploratory effectiveness analyses suggested that relative to improvement in controls, WED is 
associated with a potentially clinically important worsening in depressive symptoms (p=.006) and a 
non-significant trend for a reduction in healthy dietary behaviour (p=.057). There was no significant 
effect on other outcomes. The exploratory nature of the study, however, necessitates that the 
observed effects are interpreted with caution, and both the feasibility and effectiveness findings 
may be an artefact of the sample obtained. The evidence for the feasibility of WED in primary care 
diabetes was hence mixed, and in an unevaluated environment it may cause iatrogenic harm. On 
balance, WED is apparently not appropriate for use in this context in its current format. At most, 
further research with a more appropriate sample is required. The feasibility that was demonstrated 
and the unmet need identified suggest that this may be a worthy endeavour. 
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Introduction 
Diabetes substantially increases the risk of depression, even lower-level depressive symptoms (Aarts 
et al., 2009), which demonstrate the greatest prevalence afflicting over 60% of patients (Gonzalez et 
al., 2007), are prodromal to severe symptoms, and impact clinical outcomes (e.g. self-management 
behaviours) (Gonzalez et al., 2007) and perceived health status (Nichols et al., 2007). Research 
suggests a bidirectional association between diabetes and depression (Renn et al., 2011), yet the 
mechanisms are unclear. Some evidence implicates emotional distress relating to diabetes and its 
management, ‘diabetes distress’, suggesting that interventions targeting this may optimise 
improvement in depression (Pouwer et al., 2005).   
  
Emotional and psychological support is inadequate in diabetes, particularly for mild to moderate, or 
‘lower-level’, need and in primary care where this would be managed  (Trigwell et al., 2008), 
spurring policy imperatives prioritising this (NHS Diabetes and Diabetes UK, 2010). Service provision 
has improved with initiatives such as Improving Access to Psychological Therapies (IAPT), yet access 
issues persist particularly in long-term physical conditions.  
 
WED is an intervention in which thoughts and feelings regarding a stressful event are disclosed for 
15-20 minutes for three to four days within a short time period (Pennebaker and Beall, 1986). Over 
100 RCTs have reported health improvements for a diverse range of populations including healthy 
participants (Smyth, 1998) and those with psychological problems (e.g. depression) (Stice et al., 
2007) and long-term physical conditions such as arthritis, cancer and chronic pain. Systematic 
reviews of the original WED paradigm in long-term physical conditions, albeit no diabetes 
populations, suggest a small but clinically important improvement in psychological morbidity and 
perceived health status (Dennick 2012, Frisina et al., 2004).  
 
Consistent with the National Institute for Health and Clinical Excellence (NICE) guidelines for patients 
with lower-level depression and chronic physical health problems including diabetes, WED is a low-
intensity intervention that would serve the large proportion of individuals with diabetes and unmet 
lower-level emotional and psychological need in primary care (NHS Diabetes and Diabetes UK, 2010).  
It is consistent with other self-administered lower-level psychological interventions advocated by 
NICE (e.g. computerised cognitive behavioural therapy (cCBT), yet it is comparatively inexpensive, 
widely available and hence potentially appropriate for widespread dissemination to meet the 
substantial population need in primary care.  
 
A number of potential influencing mechanisms mirroring those underpinning existing interventions 
(i.e. CBT) have received empirical support, for example the cognitive and emotional processing 
approach in which submitting a stressor to a linguistic format and coherent narrative facilitates 
organisation, understanding and assimilation. Specifically, word use reflecting cognitive and 
emotional processing is observed across writing sessions and associated with improvement in 
outcomes (Pennebaker et al., 1997). As such, WED has a sound theoretical grounding for improving 
health. WED is also theoretically appropriate in targeting stressors and presumably distress; 
improvement in depressive symptoms may be optimised. Moreover, an independent influence on 
self-management behaviours and HbA1c may be addressed (Fisher et al., 2007). 
 
Before investment in a costly, large scale trial and certainly prior to consideration of WED for use in 
clinical practice, a trial is required to establish acceptability and feasibility, estimate potential 
benefit, and elicit trial protocol design issues. As such, many initial WED studies with patients with 
long-term physical conditions have been exploratory randomised controlled trials (RCTs) comprising 
small samples (n=30-50) (Dennick, 2012). No studies have tested the feasibility of WED for primary 
care patients with diabetes. The present study was a feasibility trial of WED for UK primary care 
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patients with Type 2 diabetes, with exploration of its potential benefit for depressive symptoms and 
associated outcomes.  
 
 
Participants and Methods 
Study Design and Population 
The study was a feasibility RCT with three month follow up (ISRCTN 18442976). Recruited were 
adults with Type 2 diabetes aged ≥18 years and diagnosed for at least six months. Exclusion criteria 
were diagnosed psychiatric disorder, depression treatment/psychological therapy, history of self-
harm or general practitioner (GP) assessment as unsuitable. Recruitment was via mass mail out to 
eligible patients on local GP registers, supplemented with advertisements on online diabetes support 
groups (eligibility confirmed by self-report). The study was approved by the Warwickshire NHS 
Research Ethics Committee. Ethical review necessitated that eligibility was tightened to ensure 
exclusion of individuals at risk of re-traumatisation via WED yet not under current care by GPs. 
Specifically an eligibility check was introduced such that participants scoring ≥16 on the Centre for 
Epidemiological Studies Depression (CES-D) scale were excluded and referred to their GP. This 
threshold has adequate sensitivity for detecting major depressive disorder (MDD) according to 
diagnostic interview in diabetes (Fisher et al., 2007). GPs were additionally required to consent at 
recruitment to deal with patients identified as experiencing potentially significant depressive 
symptoms, or experiencing screening or writing negatively. 
 
 
Randomisation, Allocation Concealment and Blinding 
Participants provided written informed consent, baseline data and were randomised to the 
intervention or control (1:1), stratified by recruitment approach and blocked with random block 
sizes of four, six and eight. A list of random numbers allocated sealed, opaque, serially numbered 
writing packs, which a researcher mailed blind and in sequence each time a primary care patient was 
enrolled. Support group participants received materials electronically; the project supervisor 
provided successive allocations to the researcher each time a participant was enrolled. Patients’ 
group allocations were also withheld from GPs. 
 
 
Intervention 
Both groups were instructed to write at home in private for 20 minutes on three days over one 
week. Intervention participants were prompted to write their thoughts and feelings about any 
stressful experience over the last month or current concern (i.e. not specifically diabetes-related). 
Switching topics across sessions was permitted. Controls wrote a description of the previous days’ 
activities, without prompt to discuss thoughts or feelings in order to distinguish writing from 
content. To prevent inference of one’s group assignment the control exposure was identical bar the 
writing foci, and participants were informed that the study purpose was to explore whether writing 
about different aspects of life improves health. Primary care patients handwrote their disclosure, 
whereas support group participants typically typed. Usual care and treatment seeking were not 
restricted. 
 
 
Assessment of Feasibility 
Feasibility was assessed on recruitment (practices and patients), compliance (return of writing, 
number of sessions completed and time spent writing per session), acceptability (reasons for not 
returning writing or completing the sessions as required), and intervention fidelity (degree of 
emotional disclosure in each group). Handwritten essays were transcribed verbatim and emotional 
disclosure was objectively quantified via the Linguistic Inquiry and Word Count (LIWC) software. This 
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derives the percentage of words belonging to pre-defined categories of word use, including those 
reflecting cognitive and emotional processing; positive emotion (e.g. love, nice and sweet), negative 
emotion (e.g. hurt, ugly and nasty), insight (e.g. think, how and consider) and causation (e.g. 
because, effect and hence). 
 
 
Assessment of Potential Benefit 
The primary outcome was depressive symptoms assessed with the CES-D (Radloff, 1977). Higher 
scores represent greater symptom severity. Internal reliability for the current sample was .67. 
Secondary outcomes were diabetes distress assessed with the Problem Areas in Diabetes (PAID) 
scale (Polonsky et al., 1995), perceived health-status measured with the EQ-5D, and diabetes self-
care behaviours assessed with the Revised Summary of Diabetes Self-care Activities (SDSCA) 
questionnaire (Toobert et al., 2000). 
 
 
Baseline Comparability and Statistical Analysis 
The baseline data were inspected for systematic group differences of a notable magnitude on 
prognostic variables. Potential benefit was assessed in accordance with intention to treat (ITT), with 
imputation by baseline observations carried forward (as available). A pre-specified complete case 
sensitivity analysis tested the validity of the ITT assumptions. Analyses were conducted using SPSS 
for Windows. Analysis of covariance (ANCOVA) assessed the between-group difference in each 
outcome at follow up, controlling for age, gender and outcome at baseline. Mean differences and 
the associated 95% Confidence Intervals (CIs) were derived to estimate the magnitude and direction 
of potential effects given that the study was exploratory and not purposefully powered. A five-point 
difference on the CES-D was considered potentially clinically important as this discriminates between 
important levels of severity. Intervention fidelity was examined with a mixed factorial analysis of 
variance (ANOVA) testing between-group differences in the percentage of words reflecting 
emotional disclosure (averaged across writing sessions for each of the four aforementioned 
categories of word use). The consistency of the main effect across the categories of word use was 
determined with planned contrasts and effect size r, interpreted at .10, .30 and .50 as small, 
medium-sized and large respectively (Cohen, 1988). 
 
 
Results 
Patient Recruitment, Characteristics and Baseline Comparability 
Of the individuals invited, 106(6%) expressed an interest in the study. Reasons for non-participation 
could not be formally collected, yet information volunteered and expressed within forums suggested 
scepticism about the benefit of writing, concerns about literacy and the likelihood of 
implementation, and preferences for practical support (e.g. free monitoring strips) and writing in 
forums. There were, however, some individuals who endorsed a belief in the value and benefit of 
writing. Notably, 31(36%) of those completing the eligibility check screened positive for potentially 
significant depressive symptoms (CES-D ≥16), suggesting an unmet treatment need. Participant flow 
and reasons for non-return of materials are provided in Figure 1. 
 
Forty-one participants, 25 men and 16 women, with a mean age of 56.6, BMI of 30, HbA1c of 53 
mmol/mol (7%) and duration since diabetes diagnosis of seven years were enrolled (Table 1). Sixty 
one percent were male, 98% described themselves as White British, 66% had at least five GCSE 
grades A-C (or equivalent), 61% were currently treated with oral diabetes medication and 51% had 
≥1 complications. The intervention groups were comparable.  
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Compliance 
Fourteen (61%) intervention and 13(72%) control participants returned their writing, with 12 in each 
group (89%) completing all sessions; one patient completed two sessions (WED) and two completed 
one (WED and control). On average, the allotted time was adhered to; median (range) minutes 
(averaged across writing sessions): 23(20-77) (WED) and 23(10-283) (controls). There were, 
however, outliers; one WED participant and a control that emotionally disclosed wrote for over an 
hour in one or more sessions, one of whom noted breaks within sessions. Thirty-two participants 
(78%) were followed up at three months, of whom 12(67%) WED and 13(93%) control participants 
had returned their writing.  
 
 
Intervention Fidelity 
Intervention fidelity was confirmed. WED essays comprised more words reflecting emotional 
disclosure relative to controls’ (p=.000, r=.84), which was consistent for positive emotion, negative 
emotion and insightful word use (p>.05) yet less pronounced for causal word use (p=.000, r=.65). 
WED participants displayed little continuity in the topics discussed within and across sessions. 
Approximately a third wrote about diabetes to a notable degree, which on average accounted for a 
third of the topics they disclosed. In addition to disclosing stressors, approximately half also wrote 
about positive and neutral diabetes and non-diabetes topics to a notable extent. On average, this 
accounted for over half of the topics they discussed. Control participants typically wrote an objective 
description of their previous day. However a third exhibited some degree of emotional disclosure 
typically limited to discussion of stressors in the context of daily activities, albeit one participant 
disclosed in a manner consistent with the intervention. 
 
 
Acceptability 
Negative appraisals of WED (i.e. reasons for not completing/returning writing but also issues raised 
by those completing it) related to the intervention; the associated burden, concern about literacy 
and no desire to or difficulty writing about feelings, but also the sample obtained; physical (age-
related) difficulty writing and not having anything to write about. Participants attributed the latter to 
an absence of problems and no inclination to dwell on stressors, and in fact a number of these 
individuals were amongst those that additionally wrote about positive/neutral topics. These 
participants also indicated that thinking about what they were concerned enough to write about 
notably diminished their positive mood, evoked negativity and promoted rumination on incited 
stressors.  
 
 
Potential Benefit 
The intervention group exhibited significantly greater depressive symptom severity relative to 
controls at follow up (p=.006), a mean difference that was potentially clinically important (4.8), and 
there was a non-significant trend for worse dietary behaviour (i.e. less consumption of fruits and 
vegetables and greater consumption of high fat foods) (p=.057). These effects reflected worsening 
for the WED group, albeit also improvement for controls from baseline to follow up. There was no 
significant effect on other secondary outcomes (p>.05) (Table 2). The sensitivity analysis 
corroborated these findings. 
 
 
Discussion 
The evidence for the feasibility of WED for primary care diabetes was mixed. A substantial number 
of patients with Type 2 diabetes were not interested in WED and did not return and presumably 
complete it, and negative appraisals were observed amongst those agreeing to participate and those 
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completing it. However some patients were interested, an unmet treatment need was identified 
amongst them, and those that completed WED were willing and able to do so with some exceeding 
the request.  
 
Recruitment of practices was also modest. Of those approached (n=113), 8(7%) of practices agreed 
and 5(4%) were retained. Recruitment from support groups was also not an effective alternative for 
accessing potential patients; of the 20 groups approached, only 5(25%) responded to the request 
and agreed. Reasons for practice non-participation were principally practice workload, and the 
absence of external funding and thus ineligibility for inclusion on the National Institute for Health 
Research Clinical Research Network (NIHR CRN) Portfolio (i.e. non-payment and resource costs). GPs 
infrequently cited WED as the reason. At most there was concern about eliciting emotional issues 
with which they would have to deal (Dennick, 2012). This reticence is reported in other feasibility 
studies of therapeutic writing in primary care (Hannay and Boulton, 1999), yet previous writing 
studies have reported primary care patients, patients with long-term physical conditions and those 
with lower-level depressive symptoms typically experience the intervention positively without 
requesting additional support (Hannay and Boulton, 1999, Stice et al., 2007, Broderick et al., 2004).  
 
Delivering WED as it was in the present endeavour may, however, cause iatrogenic harm. A possible 
explanation for this finding and in part the mixed acceptability observed could be the sample 
obtained, which did not represent the target population requiring support; the participants were in 
good control of their diabetes and the baseline CES-D score was well below that reported for people 
with diabetes in the community (Zhang et al., 2005). WED may have evoked rather than resolved 
previously unacknowledged stressors, an effect which extended beyond depressive symptoms to 
behaviour reflecting ‘comfort eating’, possibly via the change in depressive symptoms albeit this is 
not known. Indeed, many WED participants indicated they were generally well adapted yet were 
prompted to discuss troubling issues, for example family and health problems. It must be noted, 
however, that three months may be insufficient to observe the full trajectory of WEDs effects. A six 
month follow up was intended yet had to be abandoned owing to the delay imposed by the ethical 
review and recruitment issues encountered. This change also meant that HbA1c obtained from 
medical records could not be reliably measured as an outcome. 
 
Previous WED studies have reported detrimental effects in acutely stressed populations (Solano et 
al., 2007, Batten et al., 2002) but also unselected students (Honos-Webb et al., 2000, Rogers et al., 
2007). In these studies, this was attributed to evocation yet avoidance and or an absence of 
resolution of stressors. Indeed, in the present endeavour, there was little evidence of continuity in 
the topics discussed by WED participants who had difficulty identifying and disclosing stressors. 
Interestingly, a WED study in cancer patients employed a similar eligibility check and also observed 
this phenomenon, yet did not assess outcomes (Bruera et al., 2008). There was also a bias to males 
in the current sample, who perhaps experienced particular difficulty in processing and resolving 
evoked stressors; participant feedback supported this assertion, and a body of evidence suggests 
WED may worsen outcomes for those with lower emotional processing ability (Lumley, 2004). 
 
Importantly, the ethical review requirement to increase the eligibility threshold to essentially those 
without depressive symptoms was largely responsible for the sample obtained. In hindsight, perhaps 
some excluded participants could have safely participated; in diabetes 70% of those scoring ≥16 on 
the CES-D do not meet the criteria for MDD according to diagnostic interview (Fisher et al., 2007). 
Future endeavours could include those scoring between the thresholds for lower-level and 
significant symptoms on a measure derived from the Diagnostic and Statistical Manual of Mental 
Disorders fourth edition (DSM-IV) diagnostic criteria. In fact, the Beck Depression Inventory (BDI) 
exhibits a superior positive predictive value whilst maintaining sensitivity for detecting MDD in 
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diabetes (Lustman et al., 1997). Previous WED trials adopting this approach have reported 
improvement in depressive symptoms rather than deleterious effects (Stice et al., 2007). 
 
The exploratory nature of the study, however, necessitates that the observed effects are interpreted 
with caution, not least the recruitment rate and sample size. The multiple exploratory analyses also 
suggest a risk of Type 1 errors. The purpose of the study was to explore acceptability and feasibility 
and estimate the potential benefit in this patient group and setting, and identify trial protocol design 
issues prior to a costly effectiveness trial in a large, representative sample. Nonetheless, it must 
additionally be noted that one third of the participants did not return and presumably complete 
their writing, and effects were also partly explained by an improvement for controls completing the 
neutral writing task. Other WED studies in long-term physical conditions have observed the latter 
phenomenon, attributed in one study to a transient increase in perceived control for control 
participants (Gillis et al., 2006). Randomisation and allocation concealment were apparently 
successful with no evidence of selection bias, and attrition was acceptable and apparently balanced. 
Participants reported that the control task lacked face validity though, and a check of blinding 
suggested this was compromised for approximately a quarter of the participants in each group.  
 
Interestingly, the present study did not support the assertion that WED impacts distress and 
influences depressive symptoms via this. In fact, of interest was that a change in depressive 
symptoms yet not diabetes distress was observed. It is possible that these constructs are not as 
closely related as suggested by the literature. Indeed, it is cautioned that they overlap yet share only 
23% of their variance (Gonzalez et al., 2011), and they exhibit independent associations with clinical 
outcomes (Fisher et al., 2007). Furthermore notable diabetes distress was observed in the sample 
obtained in the absence of depressive symptoms, which is less likely treated than the latter. 
Alternative intervention for diabetes distress is indicated.  
 
This feasibility trial is the only one to consider WED for UK primary care patients with diabetes. This 
is important given the clinical issue of unmet lower-level emotional and psychological need in 
diabetes, which necessitates management with inexpensive, low-intensity intervention in primary 
care. On balance, WED is apparently not suitable for use in primary care diabetes in its current 
format. At best, further research with a more appropriate sample is required. The feasibility that was 
demonstrated and the unmet need identified suggest that this may be a worthy endeavour. 
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